Through the NIHR Imperial BRC, we harness the world-leading discovery science base of all the Faculties within Imperial College London, creating a vibrant pipeline of excellent early translational research. We have structured our BRC to reach deep into the Faculties of Medicine, Engineering and Natural Sciences to identify the latest laboratory-based findings with a view to nurturing and translating these into new devices, diagnostics and therapeutics which demonstrate real patient benefit.

Our Joint Translation Fund provides funding to support this translational activity at an early stage, when the basic science needs support to demonstrate proof-of-concept before considering whether to apply for further large-scale funding. Industrial expertise is embedded in this system, with a view to generating innovative products with the potential for future commercialisation.